InsidersTradesSigma
argenx SE: management transactions · Netherlands · AFM
AFM:argenx-seNL·AFMMcap 50.0Bn€Healthcare & Pharma
Browse the full management transaction log of argenx SE, a listed issuer based in Netherlands. Shares trade on NL NL, under the supervision of AFM. Operating in the Healthcare & Pharma sector, argenx SE has recorded 253 insider filings. Market capitalisation: €50bn. The latest transaction was disclosed on 6 May 2026 — Purchase. Among the most active insiders: T.J.M. van Hauwermeiren. All data is openly available.
253
Insider Decl.
0
Thresholds
€175,418
68 ops.
Buy Volume
€36m
57 ops.
Sell Volume
Financial data
Analyst consensus
22 analystsStrong buy
691.70 €Target 1022.11 €1245.05 €
Valuation
PER (trailing)35.5x
PER (forward)25.6x
P/Book168.9x
Beta-0.06
Balance sheet & cash
Market cap49.95 Bn€
Debt / Equity1%
Profitability & ownership
% insiders0.0%
% institutions47.4%
Last declaration on 6 May 2026
Declarations0 total
No declarations found
0 of 0 declarations
About argenx SE
argenx SE is a biopharmaceutical company focused on developing therapeutic antibodies for treating autoimmune diseases and cancers. It is listed on the Euronext Amsterdam market.
